Quasispecies, error catastrophe, and the antiviral activity of ribavirin.

Ribavirin is the first synthetic, broad-spectrum antiviral nucleoside. Despite its more than 30 year history, the mechanism of action of this compound remains unclear and somewhat controversial. Recent data suggest the possibility that the activity of ribavirin against RNA viruses is a reflection of incorporation of ribavirin into the viral genome. Because ribavirin incorporation is not specific, this event leads to lethal mutagenesis of the virus population. The data supporting this new proposal for the mechanism of action of ribavirin are reviewed herein. In addition, we discuss briefly the challenges that remain for development of lethal mutagenesis as an effective antiviral strategy.

[1]  L. Krilov.  Respiratory syncytial virus: Update on infection, treatment, and prevention , 2001, Current infectious disease reports.

[2]  J. Mullins,et al.  Lethal mutagenesis of HIV by mutagenic ribonucleoside analogs. , 2000, AIDS research and human retroviruses.

[3]  V. Stollar,et al.  Mutations that confer resistance to mycophenolic acid and ribavirin on Sindbis virus map to the nonstructural protein nsP1. , 1991, Virology.

[4]  E. Domingo,et al.  Efficient Virus Extinction by Combinations of a Mutagen and Antiviral Inhibitors , 2001, Journal of Virology.

[5]  B. Chiang,et al.  Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level. , 2000, Journal of hepatology.

[6]  E. De Clercq,et al.  Molecular approaches for the treatment of hemorrhagic fever virus infections. , 1993, Antiviral research.

[7]  J. Arnold,et al.  Poliovirus RNA-dependent RNA polymerase (3D(pol)). Assembly of stable, elongation-competent complexes by using a symmetrical primer-template substrate (sym/sub). , 2000, The Journal of biological chemistry.

[8]  D. M. Brown,et al.  Synthesis and duplex stability of oligonucleotides containing cytosine-thymine analogues. , 1989, Nucleic acids research.

[9]  David A. Steinhauer,et al.  Mutation Frequencies at Defined Single Codon Sites in Vesicular Stomatitis Virus and Poliovirus Can Be Increased Only Slightly by Chemical Mutagenesis , 1990, Journal of virology.

[10]  C. Otsuka,et al.  HIGHLY EFFICIENT RANDOM MUTAGENESIS IN TRANSCRIPTION-REVERSE-TRANSCRIPTION CYCLES BY A HYDROGEN BOND AMBIVALENT NUCLEOSIDE 5′-TRIPHOSPHATE ANALOGUE: POTENTIAL CANDIDATES FOR A SELECTIVE ANTI-RETROVIRAL THERAPY , 2001, Nucleosides, nucleotides & nucleic acids.

[11]  D. R. Tershak,et al.  Guanidine-resistant mutants of poliovirus have distinct mutations in peptide 2C , 1989, Journal of virology.

[12]  A. Jakubowski,et al.  Pyrazofurin metabolism, enzyme inhibition, and resistance in L5178Y cells. , 1979, Cancer research.

[13]  Edward C. Holmes,et al.  Is the Quasispecies Concept Relevant to RNA Viruses? , 2002, Journal of Virology.

[14]  W. Müller,et al.  Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent. , 1977, Biochemical pharmacology.

[15]  C. Cameron,et al.  Hepatitis C Virus RNA-dependent RNA Polymerase (NS5B) as a Mediator of the Antiviral Activity of Ribavirin* , 2001, The Journal of Biological Chemistry.

[16]  L. Philipson,et al.  Inhibition of Influenza Virus Ribonucleic Acid Polymerase by Ribavirin Triphosphate , 1977, Antimicrobial Agents and Chemotherapy.

[17]  R. Handschumacher,et al.  Clinical, Biological, and Biochemical Effects of Pyrazofurin , 1978 .

[18]  S. Goodman,et al.  Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials. , 2001, JAMA.

[19]  J. Huggins.  Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. , 1989, Reviews of infectious diseases.

[20]  R. J. Bauer,et al.  Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Arnold,et al.  The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen , 2000, Nature Medicine.

[22]  E. Domingo,et al.  The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. , 1985, Gene.

[23]  E. Clercq.  Antiviral agents : characteristic activity spectrum depending on the molecular target with which they interact , 1993 .

[24]  D. Loakes,et al.  Survey and summary: The applications of universal DNA base analogues. , 2001, Nucleic acids research.

[25]  R. K. Robins,et al.  Broad-Spectrum Antiviral Activity of Virazole: 1-f8- D-Ribofuranosyl- 1,2,4-triazole- 3-carboxamide , 1972, Science.

[26]  T. Traut,et al.  Physiological concentrations of purines and pyrimidines , 1994, Molecular and Cellular Biochemistry.

[27]  W. Müller,et al.  Virazole (1-β-d-ribofuranosyl-1,2,4-triazole-3-carboxamide; A cytostatic agent , 1977 .

[28]  E. Domingo,et al.  Quasispecies Theory in Virology , 2002, Journal of Virology.

[29]  C. Cameron,et al.  RNA virus error catastrophe: Direct molecular test by using ribavirin , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Zimmerman,et al.  Metabolism of 5-amino-1-beta-D-ribofuranosylimidazole-4-carboxamide and related five-membered heterocycles to 5'-triphosphates in human blood and L5178Y cells. , 1978, Biochemical pharmacology.

[31]  R. Lanford,et al.  Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes , 2001, Journal of Virology.

[32]  B. Bacon,et al.  Combination of interferon and ribavirin in chronic hepatitis C: Re‐treatment of nonresponders to interferon , 2001, Hepatology.

[33]  Břetislav Rada,et al.  ANTIVIRAL ACTION AND SELECTIVITY OF 6‐AZAURIDINE , 1977, Annals of the New York Academy of Sciences.

[34]  D. Yeshurun,et al.  The effect of antiviral therapy on t ( 14 ; 18 ) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection , 2001 .